Media Advisory: Media Registration Now Available for BIO National Venture Conference
WASHINGTON, D.C. (Wednesday, February 25, 2009) -
What: Media registration is now available for the BIO National Venture Conference. Hosted by the Biotechnology Industry Organization (BIO), the conference is a national forum to connect select early-stage, private biotech companies with an elite group of healthcare venture investors.
Media registration is available at http://bnvc.bio.org/opencms/BioVenture/2009/Media/index.jsp
Who: The conference will feature keynote sessions and workshops highlighting industry trends, with a special focus on success factors for early-stage companies, market trends and financing. Through formal and informal networking opportunities, industry CEOs and venture capital leaders will have the opportunity to discuss emerging technologies and partnership opportunities.
When: March 31 – April 1, 2009
Where: Sheraton Boston Hotel
For more information on the BIO National Venture Conference, please visit http://bnvc.bio.org.
Upcoming BIO Events
March 16-18, 2009
BIO IP Counsels' Committee Conference
March 25–27, 2009
BIO National Venture Conference
March 31–April 1,2009
BIO Windhover 2009
April 13-15, 2009
New York, NY
BIO-LES Business Development Basics Course
May 15–17, 2009
BIO-LES Advanced Business Development Course
May 15–17, 2009
BIO Executive Presentation Workshop
May 17, 2009
BIO Human Resources Conference
May 17-19, 2009
2009 BIO International Convention
May 18-21, 2009
June 9-10, 2009
World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.